In prostate cancer, the role of BCL2 expression in disease progression is currently not fully understood: Stackhouse and coworkers reported a positive correlation between BCL2 tumor staining and biochemical recurrence in prostatectomy specimens, but not in prostate biopsies [6]. Here, BCL2 is linked to prostate cancer.